Reduction in weight and BMI and changes in Co-morbidities following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Bahrain: A five year longitudinal study

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-5

  Khalifa, Khalid Al ^a   Violato, Claudio ^b   Ansari, Ahmed Al ^a,b  

^a BAHRAIN DEFENSE FORCE HOSPITAL   (Bahrain)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adjustable gastric band; Bariatric surgery; Excess weight loss

Indexed keywords

EID: 84876582860     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-19     Document Type: Article

References (19)

1. Ahroni JH, Montgomery KF, Watkins BM (2005) Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 15:641-647
2. Bacci V, Basso MS, Greco F et al (2002) Modifications of metabolic and cardiovascular risk factors after weight loss induced by laproscopic gastric banding. Obes Surg 12:77-82
3. Brancatisano A, Wahlroos S, Brancatisano R (2007) Improvement in comorbid illness after placement of the Swedish adjustable gastric band. Surg Obes Rel Dis 17:229-235
4. Dargent J (2004) Surgical treatment of morbid obesity by adjustable gastric band: the case for a conservative strategy in the case of failure-a 9-year series. Obes Surg 14:986-990
5. Dixon JB, O'Brien PE (2002) Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 184:51S-54S
6. Frigg A, Peterli R, Peter T et al (2004) Reduction in co-morbidities 4 years after laparoscopic adjustable gastic banding. Obes Surg 14:216-223
7. Karmali S, Kadikoy H, Brandt ML et al (2011) What is My goal? expected weight loss and comorbidity outcomes among bariatric surgery patients. Obes Surg 21:595-603
8. Kinzl JF, Schrattenencker M, Traweger C et al (2007) Quality of life morbidly obese patients after surgical weight loss. Obes Surg 17:229-235
9. Koba S, Hirano T, Sakaue T et al (2000) Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels. J Cardiol 36:371-378
10. Korenkov M, Shah S, Sauerland S et al (2007) Impact of laparoscopic adjustable gastric banding on obesity co-morbidity in the medium-and long-term. Obes Surg 17:679-683
11. Leonardo F, Fragasso G, Rosano GMC (1997) Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 80:789-790
12. National Institutes of Health Consensus Development Conference Statement (1991) Gastrointestinal surgery for severe obesity. 9(1):1-20, Mar 25-27
13. Omana JJ, Nguyen SQ, Herron D (2010) Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastricbanding. Sur Endosc 24:2513-2517
14. Pontiroli AE (2008) Surgical treatment of obesity: Impact on diabetes and other comorbidities. Nutr, Meta & Cardio 18:1-6
15. Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinal Metab 87:3555-3561
16. Titi M, Jenkins JT, Modak P et al (2007) Quality of life and alteration in comorbidity following laparoscopic adjustable gastric banding. BMJ 83:487-491
17. Wang Y, Beydoun MA, Liang L et al (2008) Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obes Surg 16:2323-2330
18. Weiss HG, Nehoda H, Labeck B et al (2001) Pregnancies after adjustable gastric banding. Obstet Surg 11:303-306
19. World Health Organization (2011) NCD country profile. Metabolic risk factor trends. Available at: //www.who.int/entity/nmh/countries/bhr_en.pdf